The diagnosis of inflammatory bowel disease (IBD) remains a challenging task despite
significant increase in the understanding of the disease aetiology and pathogenesis. Recent …

Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

Background The aetiology of inflammatory bowel disease (IBD) remains poorly understood.
Recent evidence suggests an important role of gut microbial dysbiosis in IBD, and this may …

Inflammatory bowel disease (IBD) diagnosis depends on criteria based on histological,
endoscopic, radiological, and clinical results. These studies show drawbacks as being …

Abstract Background Volatile organic compounds [VOCs] show promise as potential
biomarkers of for ulcerative colitis and Crohn's disease, two chronic, idiopathic …

The investigation of a novel, cheaper method of diagnosing inflammatory bowel disease
(IBD) is an area of active research. Recently, investigations into the metabolomic profile of …

Introduction: Inflammatory bowel disease (IBD) is a common disease with significant
morbidity. Noninvasive diagnostic techniques are lacking in IBD. Currently, fecal calprotectin …

Introduction VOCs can be utilised as non invasive biomarkers for gastrointestinal diseases
such as IBD, as changes in VOCs reflect internal metabolical and pathological processes …

Distinct changes can be observed in the odor of human excretions during health and
disease. Identifying underlying volatile metabolites responsible for these odorous changes …

Background There is an urgent need for cheap, reproducible, easy to perform and specific
biomarkers for diagnosis, differentiation and stratification of inflammatory bowel disease …